Clinical Trial Update: Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from a Phase Ib/II study of TG4001 in combination with Avelumab in HPV16-positive recurrent/metastatic cancers, including cervical, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Squamous Cell Carcinoma
• Cervical Cancer
• Penile Squamous Cell Carcinoma
• Vulvar Squamous Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• TG4001

Snippet

Sponsor: Transgene | Conditions: HPV-Related Carcinoma, HPV-Related Cervical Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-12-02